ALFA Filings
Every announcement, straight from the exchange
Every Strides Pharma Science other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
Strides Pharma Science Limited submitted its quarterly certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Strides Pharma Science Ltd has filed its shareholding pattern for the quarter ended June 30, 2026. This disclosure is a routine regulatory compliance requirement.
Strides Pharma recommended appointing Deloitte Haskins & Sells as statutory auditors for five years starting FY28. The transition follows mandatory audit firm rotation requirements.